We therefore propose that IMP3 biases cervical cancer cells toward a lipid-addicted state, whereas IMP3 loss shifts cells toward a mitotic-checkpoint–enriched state operating under metabolic constraint. This evidence concerns the gene IMP3 and cervical cancer.